Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
The impending Supreme Court ruling on gene patents is creating uncertainty in the molecular diagnostics sector.
A startup called Catabasis is developing drugs that hit diseases at multiple targets.
Mice tap into their own neural reward circuits with the help of a new optogenetics device.
Thanks to extensive genetic engineering, drugmakers can now brew large vats of the malaria drug artemisinin, stabilizing the world supply.